ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

October 18, 1985

Tobacco Council Lists 14 Smoking-Health Awards

July 30, 1976

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974